Related Experiment Video
Updated: Mar 22, 2026

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
Published on: June 14, 2020
Alphavirus Encephalomyelitis: Mechanisms and Approaches to Prevention of Neuronal Damage
1W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA. dgriffi6@jhu.edu.
Abstract:
Mosquito-borne viruses are important causes of death and long-term neurologic disability due to encephalomyelitis. Studies of mice infected with the alphavirus Sindbis virus have shown that outcome is dependent on the age and genetic background of the mouse and virulence of the infecting virus. Age-dependent susceptibility reflects the acquisition by neurons of resistance to virus replication and virus-induced cell death with maturation. In mature mice, the populations of neurons most susceptible to infection are in the hippocampus and anterior horn of the spinal cord. Hippocampal infection leads to long-term memory deficits in mice that survive, while motor neuron infection can lead to paralysis and death. Neuronal death is immune-mediated, rather than a direct consequence of virus infection, and associated with entry and differentiation of pathogenic T helper 17 cells in the nervous system. To modulate glutamate excitotoxicity, mice were treated with an N-methyl-D-aspartate receptor antagonist, α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor antagonists or a glutamine antagonist. The N-methyl-D-aspartate receptor antagonist MK-801 protected hippocampal neurons but not motor neurons, and mice still became paralyzed and died. α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor antagonists GYKI-52466 and talampanel protected both hippocampal and motor neurons and prevented paralysis and death. Glutamine antagonist 6-diazo-5-l-norleucine protected hippocampal neurons and improved memory generation in mice surviving infection with an avirulent virus. Surprisingly, in all cases protection was associated with inhibition of the antiviral immune response, reduced entry of inflammatory cells into the central nervous system, and delayed virus clearance, emphasizing the importance of treatment approaches that include prevention of immunopathologic damage.
Insights
Treating Sindbis virus infection with specific glutamate receptor antagonists protected neurons and prevented death in mice. This protection was linked to reduced immune response and inflammation in the central nervous system.
Area of Science:
- Neuroscience
- Immunology
- Virology
Background:
- Mosquito-borne viruses cause encephalomyelitis, leading to death and neurological disability.
- Neuronal susceptibility to virus infection and death varies with age, genetics, and virus virulence.
- In mature mice, the hippocampus and spinal cord motor neurons are most vulnerable, causing memory deficits and paralysis.
Purpose of the Study:
- To investigate neuroprotective strategies against Sindbis virus-induced encephalomyelitis.
- To evaluate the efficacy of glutamate excitotoxicity modulators in preventing neuronal damage and mortality.
- To understand the role of immune-mediated damage in disease outcome.
Main Methods:
- Mice were infected with Sindbis virus.
- Treated with N-methyl-D-aspartate receptor antagonist (MK-801), α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor antagonists (GYKI-52466, talampanel), or a glutamine antagonist (6-diazo-5-l-norleucine).
- Assessed neuronal protection, survival rates, memory function, and central nervous system inflammation.
Main Results:
- AMPA receptor antagonists protected both hippocampal and motor neurons, preventing paralysis and death.
- N-methyl-D-aspartate receptor antagonist protected hippocampal neurons but not motor neurons.
- Glutamine antagonist improved memory in surviving mice infected with avirulent virus.
- Protection correlated with reduced antiviral immune response, decreased inflammatory cell infiltration, and delayed viral clearance.
Conclusions:
- Targeting AMPA receptors offers a promising therapeutic strategy against severe alphavirus-induced neurological disease.
- Preventing immunopathologic damage is crucial for effective treatment, even if it involves modulating the immune response.
- Further research is needed to balance antiviral defense with neuroprotection.
Related Concept Videos
Arboviral Encephalitis
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

